These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2670353)

  • 1. Chirality: pharmacokinetics and pharmacodynamics in 3 dimensions.
    Williams KM
    Clin Exp Pharmacol Physiol; 1989 Jun; 16(6):465-70. PubMed ID: 2670353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chirality on pharmacokinetics and pharmacodynamics.
    Crom WR
    Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S9-14. PubMed ID: 1530005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chirality and pharmacokinetics: an area of neglected dimensionality?
    Hutt AJ
    Drug Metabol Drug Interact; 2007; 22(2-3):79-112. PubMed ID: 17708062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of chirality in clinical pharmacology].
    Le Corre P; Sado P; Le Verge R
    J Pharm Belg; 1991; 46(5):331-47. PubMed ID: 1791526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics.
    Brocks DR
    Biopharm Drug Dispos; 2006 Nov; 27(8):387-406. PubMed ID: 16944450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomers: implications and complications in developmental pharmacology.
    Eichelbaum M
    Dev Pharmacol Ther; 1992; 18(3-4):131-4. PubMed ID: 1306801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug chirality and its clinical significance.
    Hutt AJ; Tan SC
    Drugs; 1996; 52 Suppl 5():1-12. PubMed ID: 8922553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chirality--a new era of therapeutics.
    Agrawal YK; Bhatt HG; Raval HG; Oza PM; Gogoi PJ
    Mini Rev Med Chem; 2007 May; 7(5):451-60. PubMed ID: 17504180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselectivity: an issue of significant importance in clinical pharmacology.
    Lam YW
    Pharmacotherapy; 1988; 8(3):147-57. PubMed ID: 3050903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of stereochemistry in drug action and disposition.
    Caldwell J
    J Clin Pharmacol; 1992 Oct; 32(10):925-9. PubMed ID: 1447400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic consequences of stereoselective drug metabolism in man.
    Eichelbaum M
    Biochem Pharmacol; 1988 Jan; 37(1):93-6. PubMed ID: 3276323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
    Shah RR
    Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racemic mixtures: harmless or potentially toxic?
    Ehrlich GE
    Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S15-8. PubMed ID: 1530003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective drug disposition: potential for misinterpretation of drug disposition data.
    Evans AM; Nation RL; Sansom LN; Bochner F; Somogyi AA
    Br J Clin Pharmacol; 1988 Dec; 26(6):771-80. PubMed ID: 3242583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil in rabbits.
    Mori Y; Hanada K; Mori T; Tsukahara Y; Hashiguchi M; Ogata H
    Biol Pharm Bull; 2001 Jul; 24(7):806-10. PubMed ID: 11456122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into stereoselective disposition of enantiomers of a potent antithrombotic agent, S002-333 following administration of the racemic compound to mice.
    Bhateria M; Rachumallu R; Yerrabelli S; Saxena AK; Bhatta RS
    Eur J Pharm Sci; 2017 Apr; 101():107-114. PubMed ID: 28189817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemic mixture to dogs.
    Volosov A; Yagen B; Bialer M
    Epilepsia; 2000 Sep; 41(9):1107-11. PubMed ID: 10999549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential properties of enantiomers of commercially available racemates.
    Gulati V
    J Indian Med Assoc; 2007 Apr; 105(4):173-4, 176. PubMed ID: 17822184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodents.
    Isoherranen N; Yagen B; Woodhead JH; Spiegelstein O; Blotnik S; Wilcox KS; Finnell RH; Bennett GD; White HS; Bialer M
    Br J Pharmacol; 2003 Feb; 138(4):602-13. PubMed ID: 12598414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiomers in arthritic disorders.
    Williams KM
    Pharmacol Ther; 1990; 46(2):273-95. PubMed ID: 2181494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.